Laboratory for studying new methods for diagnosing and treating cancer patients based on post-genomic technologies
17 Sept 2019, 00:00
530

This laboratory can be used for:
- creating a new type of diagnostics using proteomic-metabolomial and transcriptomic data for mapping the biological fluids and tumor tissue of cancer patients;
- identifying proteomic targets based on a comparative analysis of reference proteoforms of the secretome and proteome of normal and tumor stem cells (NSCs);
- developing molecular-targeted antitumor therapy aimed at destroying the descendants of tumor stem cells and at reprogramming the tumor stem cells themselves to reduce their tumorogenic potential.
Your comment will be the first